AZR

Azora Therapeutics

AZR | NASDAQ
Chart Builder DCF Calculator
$3.81
-$0.28 (-6.85%)
At close: Nov 16, 2026, 4:00 PM ET
-6.85%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 17, 2026
27
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #4/6 (Top 67%)

Key Statistics

Market Data

Market Cap $10M
1D Range
3.58 3.95
52W Range
1.36 8.25

Valuation (TTM)

PE -0.20
PB 572.61
EV/EBITDA -0.16

Valuation (NTM)

Forward PE N/A
Forward PEG N/A
Price Target $8.50
Loading financial charts...

Profile

Azora Therapeutics is a biopharmaceutical company developing treatments for serious inflammatory diseases. Its lead program, AT177, is an oral, colon-targeted aryl hydrocarbon receptor agonist in deve...

Sector Healthcare
Employees 6
IPO Date Jul 27, 2018
Fiscal Year n/a

Latest News

Azora Therapeutics Reports 2026 Third Quarter Financial Results and Provides Business Update

4 days ago · globenewswire.com

Azora Therapeutics Reports 2026 Third Quarter Financial Results and Provides Business Update
Azora Therapeutics Appoints Board of Directors with Extensive Drug Development and Inflammatory Bowel Disease Expertise

12 days ago · globenewswire.com

Azora Therapeutics Appoints Board of Directors with Extensive Drug Development and Inflammatory Bowel Disease Expertise

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.